August 7, 2025
6,859
42
2
0.64%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:17Now PlayingEli Lilly says a new pill for obesity, similar to existing GLP-1 medications that can only be injected, is showing promise in a clinical trial.
Eli Lilly, the maker of Mounjaro and Zepbound, said Thursday that the company's new orforglipron pill can offer up to an average of 27.3 pounds of weight loss, according to results from the first of two of its Phase 3 trials that included more than 3,100 overweight or obese adults.
READ more from GMA
SUBSCRIBE to GMA on YouTube
SIGN UP to get the daily GMA Wake-Up Newsletter:
FOLLOW:
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.